A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
During this fireside chat webcast, we welcome Delcath Systems, ticker symbol DCTH on the NASDAQ. Joining us today from the company is Gerard Michel, Delcath's Chief Executive Officer. Also joining us today is Bill Maughan, Senior Research Analyst with Canaccord...
During this fireside chat we welcome Delcath Systems CEO Gerard Michel. Delcath is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. This Fireside Chat was recorded during the Lytham Partners Fall 2023 Investor...
Today's panel will delve into groundbreaking technologies, medical devices and pharmaceuticals in various stages of development to combat cancer. Joining us today are Gerard Michel, CEO of Delcath Technologies, ticker DCTH on the NASDAQ; as well as Dr. Anatoly...
Our cancer KOL Panel titled Latest Technologies to Combat Cancer features Jeremy Sobotta, CEO of Perimeter Medical, Gerard Michelle, CEO of Delcath Technologies, and Cameron Reynolds, CEO of VolitionRX. This KOL Panel was recorded during the Lytham Partners 2022...
Delcath Systems, Inc. (NASDAQ: DCTH) is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. The Company's proprietary products, HEPZATO KIT (melphalan for Injection/Hepatic Delivery System), approved for use in the...